Suchergebnisse - "De Botton, Stéphane"

PubPharm (204)

1

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia

enthalten in: bioRxiv.org | 2024

von Allouch, A. | Voisin, L. | Zhang, Y. | +9

2

Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

enthalten in: Blood advances | 2024

von DiNardo, C. | Roboz, G. | Watts, J. | +15

3

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML

enthalten in: Leukemia research | 2024

von Risueño, A. | See, W. | Bluemmert, I. | +9

4

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib - pooled analysis from clinical trials

enthalten in: Blood advances | 2024

von Montesinos, P. | Fathi, A. | de Botton, S. | +8

5

Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression

enthalten in: Leukemia & lymphoma | 2023

von Stein, E. | de Botton, S. | Cluzeau, T. | +16

6

CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia

enthalten in: Journal of clinical medicine | 2023

von Saleh, K. | Pasquier, F. | Bigenwald, C. | +3

7

Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies : A phase 1 study

enthalten in: American journal of hematology | 2023

von DiNardo, C. | De Botton, S. | Pollyea, D. | +12

8

Standardising acute myeloid leukaemia classification systems : a perspective from a panel of international experts

enthalten in: The Lancet. Haematology | 2023

von Shallis, R. | Daver, N. | Altman, J. | +38

9

When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm : Lessons from mistakes

enthalten in: EJHaem | 2023

von Willekens, C. | Chahine, C. | Dragani, M. | +17

10

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia : an ALFA study

enthalten in: Blood advances | 2023

von Vasseur, L. | Fenwarth, L. | Lambert, J. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]